SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis

Bibliographic Details
Main Author:	Josef Finsterer MD, PhD
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-02-01
Series:	Journal of Investigative Medicine High Impact Case Reports
Online Access:	https://doi.org/10.1177/2324709621998472

Similar Items

Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
by: Josef Finsterer, et al.
Published: (2021-03-01)

Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2021-01-01)

Does SARS-CoV-2 truly cause infectious myopathy?
by: Josef Finsterer, et al.
Published: (2021-03-01)

SARS-CoV-2 Infection with Associated Rhabdomyolysis and Probable Myocarditis
by: Franco Murillo, et al.
Published: (2020-08-01)

SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection
by: Josef Finsterer
Published: (2020-10-01)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020-09-01)

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
by: Georg Gelbenegger, et al.
Published: (2021-08-01)

SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients
by: Cuiyan Tan, et al.
Published: (2020-11-01)

SARS-CoV-2 in Urine May Predict a Severe Evolution of COVID-19
by: Alessandro Perrella, et al.
Published: (2021-09-01)

A case of corticosteroid-responsive SARS-CoV-2 related massive rhabdomyolysis
by: Maria Cunha, et al.
Published: (2020-01-01)

SARS-CoV-2(COVID-19)
by: Batool Ali Galib
Published: (2020-04-01)

SARS-CoV-2 and COVID-19
by: Wang-Huei Sheng, et al.
Published: (2020-06-01)

Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19
by: Hanan Polansky PhD, et al.
Published: (2020-06-01)

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
by: Kening Li, et al.
Published: (2020-11-01)

Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
by: Angela Huynh, et al.
Published: (2021-04-01)

The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19
by: Evelyne Bischof, MD, et al.
Published: (2021-02-01)

Pediatric COVID-19 Associated Rhabdomyolysis
by: Parisa Armanpoor, et al.
Published: (2021-09-01)

SARS-CoV-2 (COVID-19) by the numbers
by: Yinon M Bar-On, et al.
Published: (2020-03-01)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
by: Fulvio A. Scorza, et al.
Published: (2021-07-01)

The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic
by: James M. Crawford MD, PhD, et al.
Published: (2021-05-01)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
by: Josef Finsterer, et al.
Published: (2020-12-01)

Koronavirus SARS-CoV-2
by: Ksenija Geršak, MD, PhD
Published: (2020-04-01)

Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19)
by: D. E. Karateev, et al.
Published: (2020-09-01)

Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
by: Konstantinos Farsalinos, et al.
Published: (2020-01-01)

Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?
by: Jake S. O’Donnell, et al.
Published: (2021-08-01)

Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management
by: Gandhi, R.T, et al.
Published: (2022)

Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
by: Fulvio A. Scorza, et al.
Published: (2021-09-01)

Adolescent COVID-19-Associated Fatal Rhabdomyolysis
by: Huda Anwar, et al.
Published: (2020-12-01)

New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020-03-01)

COVID-19: the novel SARS-CoV-2 pandemic
by: Roberto Alfonso Accinelli, et al.
Published: (2020-04-01)

Understanding the SARS-CoV-2 to Manage COVID-19
by: Somdatta Karak, et al.
Published: (2020-09-01)

Pandemia por SARS-CoV-2 (COVID-19)
by: Julio Medina
Published: (2020-04-01)

The role of SARS-CoV-2 testing in COVID-19
by: Cole, Manisha
Published: (2021)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020-10-01)

A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2
by: Xiao-Shan Wei, et al.
Published: (2021-02-01)

Skin manifestations of a new coronovirus infection COVID-19 caused by SARS-CoV-2
by: Aleksey A. Khryanin, et al.
Published: (2020-09-01)

Anosmia-hyposmia and dysgeusia in COVID-19 may be due to SARS-CoV-2 protein mimicry of olfactory receptors
by: Robert Root-Bernstein
Published: (2020-09-01)

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study
by: Hin Chu, PhD, et al.
Published: (2020-05-01)

Evaluation of Anti-SARS-CoV-2 IgA in the Conjunctival Secretions of COVID-19 Patients
by: Mahmoud H, et al.
Published: (2021-05-01)

From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
by: Darja Kanduc
Published: (2020-07-01)